Entrepreneur and molecular microbiologist building biotechnology companies around natural products and next-generation biotherapeutics. Co-discovered Salivaricin 10 and founded Ostia Sciences to translate precision microbiome science into clinically validated products. Led the company’s IP strategy, building a defensible portfolio spanning platform patents, formulation know-how, and brand assets, while driving partnerships, manufacturing readiness, and fundraising to increase enterprise value.